Abstract Recently, there has been a growing demand for therapeutic monoclonal antibodies (MAbs) on the global market. Because therapeutic MAbs are more expensive than low-molecular-weight drugs, there have been strong demands to lower their production costs. Therefore, efficient methods to minimize the cost of goods are currently active areas of research. We have screened several enhancers of specific MAb production rate (SPR) using a YB2/0 cell line and found that coenzyme-Q 10 (CoQ 10 ) is a promising enhancer candidate. CoQ 10 is well known as a strong antioxidant in the respiratory chain and is used for healthcare and other applications. Because CoQ 10 is negligibly water soluble, most studies are limited by low concentrations. We added CoQ 10 to a culture medium as dispersed nanoparticles at several concentrations (Q-Media) and conducted a fed-batch culture. Although the Q-Media had no effect on cumulative viable cell density, it enhanced SPR by 29%. In addition, the Q-Media had no effect on the binding or cytotoxic activity of MAbs. Q-Media also enhanced SPR with CHO and NS0 cell lines by 30%. These observations suggest that CoQ 10 serves as a powerful aid in the production of MAbs by enhancing SPR without changing the characteristics of cell growth, or adversely affecting the quality or biological activity of MAbs.
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Recently, more than twenty therapeutic monoclonal antibodies (MAbs) and related proteins have been launched in the market (Shukla and Thömmes 2010; Walsh 2006 ). This success is a double-edged sword, however, because it leads to pressure on the pharmaceutical economy. Minimizing the cost of goods and maximizing antibody activity are therefore active areas of research in the development of MAbs for therapeutic use (Shields et al. 2002; Shinkawa et al. 2003; Wurm 2004) . There is also great interest in establishing a stable global supply of MAbs. Several approaches have been explored to improve MAb production in cell cultures. Over the past decade, various approaches such as genetic engineering, clone selection, medium optimization, and reactor engineering have dramatically improved production (Takenouchi and Sugahara 2003) . The addition of an enhancer has also proven effective. In the development of biotherapeutics, when an appropriate cell bank is established, we want to maintain use of the same cell bank to avoid risks derived from shifting characterization. The advantage of adding enhancers is the flexibility that can be applied at any development phase. Such enhancers should meet the following requirements: (a) be safe for operators and patients, (b) maintain the quality of the final product, (c) be cost-effective, and (d) be easy to handle. With these requirements in mind, the following enhancers have been suggested: butyrate (De Leon Gatti et al. 2007; Jiang and Sharfstein 2008; Mimura et al. 2001; Oh et al. 1993 Oh et al. , 2005 , caspase inhibitor (Arden et al. 2007) , carnosine (Yegorov et al. 2007) , glycerol (Liu and Chen 2007) , nucleosides (Carvalhal et al. 2003 ), linoleic acid (Butler et al. 1999) , lipopolysaccharide (Martin-Lopez et al. 2007 ), dimethyl sulfoxide (Ling et al. 2003; Tsao et al. 2001) , rapamycin (Balcarcel and Stephanopoulos 2001) , retinoic acid (Inoue et al. 2000) , sericin (Terada et al. 2002) , spermine (Miyazaki et al. 1998) , various sugars (Coroadinha et al. 2006) , valproic acid (Backliwal et al. 2008; Konno et al. 2006) , and vitamin A (Inoue et al. 1999 ) (summarized in Table 1 ).
Coenzyme-Q is a biosynthesized quinone that occurs widely in living organisms such as yeasts, plants, and animals and as such is also known as ubiquinone (ubiquitously occurring quinone). In higher organisms, including humans, this compound has 10 isoprenoid units in its side chain and is therefore named Coenzyme-Q 10 (CoQ 10 ; Hathcock and Shao 2006) . CoQ 10 , also known as Ubiquinone-Q 10 , is widely used as a therapeutic agent, a dietary supplement, an ingredient in cosmetic products, and various other products (Kitano et al. 2004; Müller et al. 2007; Ochiai et al. 2007 ). CoQ 10 is a lipid-soluble compound located in the inner mitochondrial membrane where it functions as a part of the electron transport chain as well as a strong endogenous lipophilic antioxidant (Turunen et al. 2004 ). CoQ 10 is commonly used as a dietary supplement, with the rationale that increasing intake of the nutrient boosts cellular metabolism, particularly in cells with energy deficiencies (Mancuso et al. 2010) . The effect of CoQ 10 has been tested on various diseases such as diabetes (Hodgson et al. 2002) , myocardial infarction (Singh et al. 1998; Soja and Mortensen 1997) , angina (Kogan et al. 1999) , and Parkinson's disease (Shults et al. 2004) , as well as in anti-breast cancer clinical trials (Portakal et al. 2000) . It is also used as adjunct therapy in patients following cardiac surgery (Chello et al. 1996; Hathcock and Shao 2006) .
CoQ 10 was found to inhibit cell growth and induce apoptosis in HeLa cells (Gorelick et al. 2004 ), but to decrease apoptosis in human T-acute lymphatic leukemia cells by inhibiting the activity of caspase-3 (Navas et al. 2002) . Therefore, the effects of CoQ 10 on apoptosis remain controversial. CoQ 10 was also shown to promote the growth of many cell lines, including HeLa, HL-60, mouse fibroblast, and bovine embryo cells (Stojkovic et al. 1999; Sun et al. 1992a Sun et al. , 1995 . Although CoQ 10 as an ingredient in various media appears to stimulate growth, there have been no reports that have directly analyzed this effect on SPR. In this paper, we report the effects of CoQ 10 on YB2/0, CHO, and NS0 cell lines.
Materials and methods
Materials
CoQ 10 (Kyowa Hakko Bio Co., Ltd., Tokyo, Japan) and Tween-80 (Tokyo Chemical Industry Co., Ltd., Tokyo, Japan) at a 1:2 weight ratio were dissolved Table 1 Reported enhancers of protein production in animal cell lines Cytotechnology (2011) (Konno et al. 2001) . We also tested other enhancer candidates including l-glutathione, alphatocopherol, l-ascorbic acid, 2-mercaptoethanol, and 2,3-dimethoxy-5-methyl-p-benzoquinone (Sigma Chemical. Co., Ltd., MO, USA).
Cell culture
In this study, the anchorage-dependent NS0 cell lines (RCB0213; Riken, Ibaraki, Japan) were cultivated in 225 cm 2 T-flasks (Asahi Glass, Tokyo, Japan). CHO (Urlaub and Chasin 1985) and YB2/0 cell lines (ATCC 1662) were cultivated in 250 mL shaker flasks (431406; Corning, NY, USA), or in 1 L bioreactors (ABLE, Tokyo, Japan; Ogawa et al. 1999) . CHO, YB2/0, and NS0 cell lines expressing proprietary recombinant mouse/human chimeric IgG1 antibody were cultured in Q-Media. Different Q-Media were prepared from ExCell TM 302 (SAFC-Bioscience, St. Louis, MO, USA), RPMI-1640 Medium, Hybridoma-SFM (serumfree medium, with added BSA and transferrin), or CD-Hybridoma (animal-derived, protein-free; Life Technologies, Carlsbad, CA, USA) depending on the cell line used. The cultures were inoculated at a density of 2 9 10 5 cells mL -1 and cultivated at 37°C with occasional feeding with serum-free Iscove's Modified Dulbecco's Medium until the decline phase. In the culture of 1 L bioreactors, the culture was maintained at pH 7.1 by CO 2 gas overlay and 1 mM Na 2 CO 3 alkaline solution at 50% DO by sparger O 2 gas.
Cell culture monitoring
The number of viable and dead cells was determined using a CEDEX TM counter (Innovatis AG, Bielefeld, Germany) by the trypan blue dye exclusion method. Off-line measurements of culture glucose and lactate were carried out using an YSI 2700 bioanalyzer (Yellow Springs Inc., OH, USA). The concentration of MAbs in the culture supernatant was determined by HPLC using a Protein A column. The 8-OHdG concentration was quantified using an ELISA kit (8-OHdG check; Japan Institute for the Control of Aging, Shizuoka, Japan).
ADCC activity
Antibody-dependent cell-mediated cytotoxicity (ADCC) was determined by 51 Cr release assay, as previously reported (Nakamura et al. 1999) .
Specific monoclonal antibody production rate
Results and discussion
CoQ 10 enhanced specific MAb production rate
When an enhancer is used as an additive to culture media for the production of commercial MAbs, consideration must be given to various factors including safety, cost, stability, stable supply, simple usage, patents, and regulations. With these restrictions in mind, we screened various compounds, which can be classified into groups related to the following: (1) nutrition, (2) anti-oxidization, (3) electron transport, (4) growth inhibition or cell cycle, and (5) stress response. In preliminary experiments using YB2/0 cells in 250-mL flasks, media supplemented with 50 lM CoQ 10 (dissolved with the aid of Tween-80) exhibited marked enhancement of SPR compared with media supplemented with only Tween-80. Such enhancement (1.26-fold) was also observed for the YB2/0 culture in a 1 L bioreactor (Fig. 1B) . Although CoQ 10 dissolved with the aid of Tween-80 exhibited enhanced SPR, CoQ 10 concentration was limited (\100 lM), and dissolution of CoQ 10 required tedious procedures. These problems were circumvented by the use of a stable dispersion of CoQ 10 nanoparticles (SANOMIT TM Q 10 ); CoQ 10 concentration was easily elevated to as high as 500 lM, and a 1.28-fold increase in SPR could be obtained (Fig. 2) . Although the promotion of cell growth by CoQ 10 (typically at 30 lM) has been reported in several cell lines (Stojkovic et al. 1999; Sun et al. 1992b Sun et al. , 1995 , our results are the first to show the enhancement of SPR by CoQ 10 .
CoQ 10 did not affect oxidative response in fed-batch cultures CoQ 10 is known as a strong antioxidant, and 8-OHdG is known as a marker for oxidative DNA damage (Takane . 2002) . We evaluated the change in 8-OHdG concentrations in fed-batch cultures to examine the antioxidant effects of Q-Media (containing 500 lM CoQ 10 ). Although SPR was enhanced by the Q-Media, the 8-OHdG concentrations (and cumulative cell density) did not change (Fig. 2) . To confirm that the enhancement of SPR by CoQ 10 was not ascribed to the antioxidant effect of CoQ 10 , we analyzed the effects of other antioxidants. None of the following compounds, namely, glutathione (B1,000 lM), alpha-tocopherol (B5,000 lM), proanthocyanidin B2 (B1,000 lM), uric acid (B1,000 lM), ascorbic acid (B1,000 lM), or 2-mercaptoethanol (B5,000 lM), enhanced SPR as expected (data not shown).
Q-Media enhanced SPR for CHO and NS0 cell lines
To examine whether the enhancement of SPR by Q-Media is a general phenomenon, we analyzed the effects of Q-Media on two additional host cell lines commonly used in MAb production-CHO and NS0. SPR was also enhanced in CHO and NS0 cell lines by 28.8 and 31.9%, respectively, and in YB2/0 by 29.0%, which suggests that Q-Media is a versatile agent for enhancing SPR. Although a 20% increase in SPR may not seem notable, this degree of enhancement is most welcome. To illustrate the potential effectiveness of such enhancement, a 20% increase in SPR could reduce the annual cost ($65 million) of obtaining 250 kg of MAbs with a yield of 1,000 mg/ L in a 10,000 L plant (Werner 2004 ) by $6 million. In fact, increases of 10%-20% in SPR of various MAbs have already been reported (Arden et al. 2007; Kim et al. 2005; Omasa et al. 2010 ).
Activities of MAbs were not changed by culturing in Q-Media
Because strict comparability to original MAbs is required when production conditions are changed, and because MAbs produced in YB2/0 cells have been known to exhibit high ADCC activities, we analyzed antigen binding and ADCC activities of MAbs expressed in YB2/0 cells that were cultured in Q-Media and regular media. MAbs produced in both media exhibited indistinguishable results for both activities (Fig. 3) , which warrants the safe use of Q-Media for enhancing SPR.
Conclusion
In this study, we found that supplementing culture media with CoQ 10 widely enhances the production rate of MAbs in YB2/0, CHO, and NS0 cells without With regular media With Q-Media 0.0E+00 2.0E+07 4.0E+07 6.0E+07 Fig. 2 
